We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Crafts Guidance for Complying With Pediatric Research Equity Act
FDA Crafts Guidance for Complying With Pediatric Research Equity Act
September 12, 2005
The FDA released draft guidance late last week on how to comply with the Pediatric Research Equity Act, which was signed into law Dec. 3, 2003, and requires new drug applications (NDAs) and biologics licensing applications (BLAs) to contain a pediatric assessment unless a waiver or deferral has been approved by the FDA.